Medication management of pediatric eating disorders

International Review of Psychiatry

Volumn 20, Issue 2, 2008, Pages 183-188

  Reinblatt, Shauna Pencer ^a,b   Redgrave, Graham W ^a   Guarda, Angela S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CISAPRIDE; CITALOPRAM; CYPROHEPTADINE; FLUOXETINE; LITHIUM; METOCLOPRAMIDE; NALTREXONE; OLANZAPINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; ZINC;

ANOREXIA NERVOSA; BEHAVIOR THERAPY; BINGE EATING DISORDER; BULIMIA; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG USE; FAMILY THERAPY; HUMAN; OBSESSION; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; STARVATION; SYMPTOMATOLOGY; UNDERWEIGHT;

ANOREXIA NERVOSA; ANTIDEPRESSIVE AGENTS; BODY WEIGHT; BULIMIA NERVOSA; CHILD; EATING DISORDERS; HUMANS; TREATMENT OUTCOME;

EID: 41749098600     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260801889120     Document Type: Review

References (38)

1. Agras, W. S., Rossiter, E. M., Arnow, B., Schneider, J. A., Telch, C. F., et al. (1992). Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: A controlled comparison. American Journal of Psychiatry, 149, 82-87.
2. American Psychiatric Association. (1994). Diagnostic criteria from DSM-IV. Washington DC: The American Psychiatric Association.
3. American Psychiatric Association. (2006). Treatment of patients with eating disorders, third edition. American Journal of Psychiatry, 163(suppl), 4-54.
4. Appolinario, J. C., Bacaltchuk, J., Sichieri, R., Claudino, A. M., Godoy-Matos, A., Morgan, C., et al. (2003). A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Archives of General Psychiatry, 60, 1109-1116.
5. Attia, E., Haiman, C., Walsh, B. T., & Flater, S. R. (1998). Does fluoxetine augment the inpatient treatment of anorexia nervosa? American Journal of Psychiatry, 155, 548-551.
6. Attia, E., Mayer, L., & Killory, E. (2001). Medication response in the treatment of patients with anorexia nervosa. Journal of Psychiatric Practice, 7, 157-162.
7. Biederman, J., Herzog, D. B., Rivinus, T. M., Harper, G. P., Ferber, R. A., Rosenbaum, J. F., et al. (1985). Amitriptyline in the treatment of anorexia nervosa: A double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology, 5, 10-16.
8. Boachie, A., Goldfield, G. S., & Spettigue, W. (2003). Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: Case reports. International Journal of Eating Disorders, 33, 98-103.
9. Brownley, K. A., Berkman, N. D., Sedway, J. A., Lohr, K. N. & Bulik, C. M. (2007). Binge eating disorder treatment: A systematic review of randomized controlled trials. International Journal of Eating Disorders, 40, 337-348.
10. Bryant-Waugh, R. J., Cooper, P. J., Taylor, C. L., & Lask, B. D. (1996). The use of the eating disorder examination with children: A pilot study. International Journal of Eating Disorders, 19, 391-397.
11. Bulik, C. M., Berkman, N. D., Brownley, K. A., Sedway, J. A. & Lohr, K. N. (2007). Anorexia nervosa treatment: A systematic review of randomized controlled trials. International Journal of Eating Disorders, 40, 310-320.
12. Dennis, K., le Grange, D., & Bremer, J. (2006). Olanzapine use in adolescent anorexia nervosa. Eating and Weight Disorders, 11, e53-e56.
13. Devlin, M. J., Goldfein, J. A., Petkova, E., Liu, L., & Walsh, B. T. (2007). Cognitive behavioral therapy and fluoxetine for binge eating disorder: Two-year follow-up. Obesity (Silver Spring), 15, 1702-1709.
14. Dreifuss, F. E., Santilli, N., Langer, D. H., Sweeney, K. P., Moline, K. A., & Menander, K. B. (1987). Valproic acid hepatic fatalities: A retrospective review. Neurology, 37, 379-385.
15. Fairburn, C. G. (2005). Evidence-based treatment of anorexia nervosa. International Journal of Eating Disorders, 37(Suppl.), S26-S30.
16. Fairburn, C. G., & Cooper, Z. (1993). The Eating Disorder Examination. In C. G. Fairburn & G. T. Wilson (Eds.), Binge eating, nature, assessment and treatment (pp. 317-360). New York: Guilford Press.
17. Fluoxetine Bulimia Nervosa Collaborative Study Group (1992). Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group. Archives of General Psychiatry, 49, 139-147.
18. Frank, G. K., Bailer, U. F., Henry, S., Wagner, A., & Kaye, W. H. (2004). Neuroimaging studies in eating disorders. CNS Spectrums, 9, 539-548.
19. Gowers, S., & Bryant-Waugh, R. (2004). Management of child and adolescent eating disorders: The current evidence base and future directions. Journal of Child Psychology and Psychiatry, 45, 63-83.
20. Grilo, C. M., Masheb, R. M., & Wilson, G. T. (2005). Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: A randomized double-blind placebo-controlled comparison. Biological Psychiatry, 57, 301-309.
21. Hudson, J. I., Hiripi, E., Pope Jr, H. G., & Kessler, R. C. (2007). The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 61, 348-358.
22. Kafantaris, V., Leigh, E., Berest, A. & Hertz, S. (2007). Pilot study of olanzapine in the treatment of anorexia nervosa. American Academy of Child and Adolescent Psychiatry 54th Annual Meeting Poster Presentation, 26 October 2007, Boston, MA.
23. Kaye, W., Gendall, K., & Strober, M. (1998). Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa. Biological Psychiatry, 44, 825-838.
24. Kaye, W. H., Nagata, T., Weltzin, T. E., Hsu, L. K., Sokol, M. S., McConaha, C., et al. (2001). Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biological Psychiatry, 49, 644-652.
25. Kotler, L. A., Devlin, M. J., Davies, M., & Walsh, B. T. (2003). An open trial of fluoxetine for adolescents with bulimia nervosa. Journal of Child and Adolescent Psychopharmacology, 13, 329-335.
26. Kotler, L. A., & Walsh, B. T. (2000). Eating disorders in children and adolescents: Pharmacological therapies. European Child and Adolescent Psychiatry, 9(Suppl.1), I108-I116.
27. McElroy, S. L., Guerdjikova, A., Kotwal, R., Welge, J. A., Nelson, E. B., Lake, K. A., et al. (2007a). Atomoxetine in the treatment of binge-eating disorder: A randomized placebo-controlled trial. Journal of Clinical Psychiatry, 68, 390-398.
28. McElroy, S. L., Hudson, J. I., Capece, J. A., Beyers, K., Fisher, A. C., & Rosenthal, N. R. (2007b). Topiramate for the treatment of binge eating disorder associated with obesity: A placebo-controlled study. Biological Psychiatry, 61, 1039-1048.
29. Mondraty, N., Birmingham, C. L., Touyz, S., Sundakov, V., Chapman, L., & Beumont, P. (2005). Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. Australasian Psychiatry, 13, 72-75.
30. Ramoz, N., Versini, A., & Gorwood, P. (2007). Eating disorders: An overview of treatment responses and the potential impact of vulnerability genes and endophenotypes. Expert Opinion on Pharmacotherapy, 8, 2029-2044.
31. Ricca, V., Mannucci, E., Mezzani, B., Di, B. M., Zucchi, T., Paionni, A., et al. (2001). Psychopathological and clinical features of outpatients with an eating disorder not otherwise specified. Eating and Weight Disorders, 6, 157-165.
32. Riddle, M. A., Geller, B., & Ryan, N. (1993). Another sudden death in a child treated with desipramine. Journal of the American Academy of Child Adolescent Psychiatry, 32, 792-797.
33. Shapiro, J. R., Berkman, N. D., Brownley, K. A., Sedway, J. A., Lohr, K. N. & Bulik, C. M. (2007). Bulimia nervosa treatment: A systematic review of randomized controlled trials. International Journal of Eating Disorders.
34. Tanofsky-Kraff, M., Yanovski, S. Z., & Yanovski, J. A. (2005). Comparison of child interview and parent reports of children's eating disordered behaviors. Eating Behaviours, 6, 95-99.
35. Treasure, J. L. (2007). Getting beneath the phenotype of anorexia nervosa: The search for viable endophenotypes and genotypes. Canadian Journal of Psychiatry, 52, 212-219.
36. Vandereycken, W. (1984). Neuroleptics in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled study with sulpiride. British Journal of Psychiatry, 144, 288-292.
37. Walsh, B. T., Kaplan, A. S., Attia, E., Olmsted, M., Parides, M., Carter, J. C., et al. (2006). Fluoxetine after weight restoration in anorexia nervosa: A randomized controlled trial. Journal of the American Medical Association, 295, 2605-2612.
38. Wilson, G. T., & Shafran, R. (2005). Eating disorders guidelines from NICE. Lancet, 365, 79-81.